APRIL is increased in serum of patients with brain glioblastoma multiforme.
A PRoliferation-Inducing Ligand (APRIL) is a cytokine with the ability to induce tumorigenesis. The aim of the study was to measure serum APRIL levels in patients with brain glioblastoma multiforme. Twenty five patients with brain tumor and a control group of 25 subjects took part in the study. APRIL was measured by the enzyme-linked immunosorbent method. The study showed increased APRIL levels in the serum of patients with brain glioblastoma multiforme compared to the control group (p < 0.05). However, there was no significant difference in the level of this cytokine between groups of patients divided according to their clinical state and tumor size (p > 0.05). Inflammation parameters such as C-reactive protein (CRP) and polymorphonuclear leucocytes (PMN) were also increased in patients with brain tumor compared to controls (p < 0.05). There was a significant correlation between APRIL and CRP and PMN (p < 0.05). Results from the study suggest that APRIL may play a role in the pathogenesis of brain glioblastoma multiforme. It is possible that anti-APRIL therapy might be useful in this disease. However, this cytokine cannot be regarded as a marker of tumor size or of severity of the clinical condition of patients.
Iłzecka
Joanna
J
Department of Neurology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland. ilzecka@onet.pl
Iłzecki
Marek
M
D001932:Brain Neoplasms / Q000097:blood* / Q000473:pathology; D002097:C-Reactive Protein / Q000378:metabolism; D016022:Case-Control Studies; D005260:Female; D005909:Glioblastoma / Q000097:blood* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000097:blood*
D053300:Tumor Necrosis Factor Ligand Superfamily Member 13; D002097:C-Reactive Protein